{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T12:57:17Z","timestamp":1793365037019,"version":"4.5.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,12,12]],"date-time":"2023-12-12T00:00:00Z","timestamp":1702339200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,12,12]],"date-time":"2023-12-12T00:00:00Z","timestamp":1702339200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003246","name":"Nederlandse Organisatie voor Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003246","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Vaccines"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Malaria transmission-blocking vaccines (TBVs) aim to induce antibodies that block <jats:italic>Plasmodium<\/jats:italic> parasite development in the mosquito midgut, thus preventing mosquitoes from becoming infectious. While the Pro-domain and first of fourteen 6-Cysteine domains (Pro-D1) of the <jats:italic>Plasmodium<\/jats:italic> gamete surface protein Pfs230 are known targets of transmission-blocking antibodies, no studies to date have discovered other Pfs230 domains that are functional targets. Here, we show that a murine monoclonal antibody (mAb), 18F25.1, targets Pfs230 Domain 7. We generated a subclass-switched complement-fixing variant, mAb 18F25.2a, using a CRISPR\/Cas9-based hybridoma engineering method. This subclass-switched mAb 18F25.2a induced lysis of female gametes in vitro. Importantly, mAb 18F25.2a potently reduced <jats:italic>P. falciparum<\/jats:italic> infection of <jats:italic>Anopheles stephensi<\/jats:italic> mosquitoes in a complement-dependent manner, as assessed by standard membrane feeding assays. Together, our data identify Pfs230 Domain 7 as target for transmission-blocking antibodies and provide a strong incentive to study domains outside Pfs230Pro-D1 as TBV candidates.<\/jats:p>","DOI":"10.1038\/s41541-023-00784-x","type":"journal-article","created":{"date-parts":[[2023,12,12]],"date-time":"2023-12-12T07:02:32Z","timestamp":1702364552000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Pfs230 Domain 7 is targeted by a potent malaria transmission-blocking monoclonal antibody"],"prefix":"10.1038","volume":"8","author":[{"given":"Maartje R.","family":"Inklaar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roos M.","family":"de Jong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ezra T.","family":"Bekkering","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hikaru","family":"Nagaoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix L.","family":"Fennemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karina","family":"Teelen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marga","family":"van de Vegte-Bolmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geert-Jan","family":"van Gemert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rianne","family":"Stoter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. Richter","family":"King","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3750-1135","authenticated-orcid":false,"given":"Nicholas I.","family":"Proellochs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2666-094X","authenticated-orcid":false,"given":"Teun","family":"Bousema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9070-8499","authenticated-orcid":false,"given":"Eizo","family":"Takashima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7415-1325","authenticated-orcid":false,"given":"Takafumi","family":"Tsuboi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0686-370X","authenticated-orcid":false,"given":"Matthijs M.","family":"Jore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,12,12]]},"reference":[{"key":"784_CR1","unstructured":"WHO. World Malaria Report 2022 (World Health Organization, 2022)."},{"key":"784_CR2","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1080\/14760584.2021.1878028","volume":"20","author":"PE Duffy","year":"2021","unstructured":"Duffy, P. E. Transmission-blocking vaccines: harnessing herd immunity for malaria elimination. Expert Rev. Vaccines 20, 185\u2013198 (2021).","journal-title":"Expert Rev. Vaccines"},{"key":"784_CR3","doi-asserted-by":"publisher","first-page":"13598","DOI":"10.1073\/pnas.0502378102","volume":"102","author":"DL Gerloff","year":"2005","unstructured":"Gerloff, D. L., Creasey, A., Maslau, S. & Carter, R. Structural models for the protein family characterized by gamete surface protein Pfs230 of Plasmodium falciparum. Proc. Natl Acad. Sci. USA 102, 13598\u201313603 (2005).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"784_CR4","doi-asserted-by":"publisher","unstructured":"Duffy, P. E. The virtues and vices of Pfs230: from vaccine concept to vaccine candidate. Am. J. Trop. Med. Hyg. https:\/\/doi.org\/10.4269\/ajtmh.21-1337 (2022).","DOI":"10.4269\/ajtmh.21-1337"},{"key":"784_CR5","doi-asserted-by":"publisher","first-page":"1799","DOI":"10.1016\/j.vaccine.2019.02.021","volume":"37","author":"M Tachibana","year":"2019","unstructured":"Tachibana, M. et al. Identification of domains within Pfs230 that elicit transmission blocking antibody responses. Vaccine 37, 1799\u20131806 (2019).","journal-title":"Vaccine"},{"key":"784_CR6","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1128\/CVI.05104-11","volume":"18","author":"M Tachibana","year":"2011","unstructured":"Tachibana, M. et al. N-terminal prodomain of Pfs230 synthesized using a cell-free system is sufficient to induce complement-dependent malaria transmission-blocking activity. Clin. Vaccin. Immunol. 18, 1343\u20131350 (2011).","journal-title":"Clin. Vaccin. Immunol."},{"key":"784_CR7","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1046\/j.1365-3024.2000.00315.x","volume":"22","author":"PJ Bustamante","year":"2000","unstructured":"Bustamante, P. J. et al. Differential ability of specific regions of Plasmodium falciparum sexual-stage antigen, Pfs230, to induce malaria transmission-blocking immunity. Parasite Immunol. 22, 373\u2013380 (2000).","journal-title":"Parasite Immunol."},{"key":"784_CR8","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/0166-6851(95)02507-3","volume":"75","author":"KC Williamson","year":"1995","unstructured":"Williamson, K. C., Keister, D. B., Muratova, O. & Kaslow, D. C. Recombinant Pfs230, a Plasmodium falciparum gametocyte protein, induces antisera that reduce the infectivity of Plasmodium falciparum to mosquitoes. Mol. Biochem. Parasitol. 75, 33\u201342 (1995).","journal-title":"Mol. Biochem. Parasitol."},{"key":"784_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-021-00423-3","volume":"7","author":"K Miura","year":"2022","unstructured":"Miura, K. et al. Elucidating functional epitopes within the N-terminal region of malaria transmission blocking vaccine antigen Pfs230. NPJ Vaccines 7, 4 (2022).","journal-title":"NPJ Vaccines"},{"key":"784_CR10","doi-asserted-by":"publisher","first-page":"945924","DOI":"10.3389\/fcimb.2022.945924","volume":"12","author":"FMT Lyons","year":"2022","unstructured":"Lyons, F. M. T., Gabriela, M., Tham, W. H. & Dietrich, M. H. Plasmodium 6-cysteine proteins: functional diversity, transmission-blocking antibodies and structural scaffolds. Front. Cell. Infect. Microbiol. 12, 945924 (2022).","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"784_CR11","doi-asserted-by":"publisher","first-page":"433.e5","DOI":"10.1016\/j.immuni.2023.01.012","volume":"56","author":"WK Tang","year":"2023","unstructured":"Tang, W. K. et al. A human antibody epitope map of Pfs230D1 derived from analysis of individuals vaccinated with a malaria transmission-blocking vaccine. Immunity 56, 433.e5\u2013443.e5 (2023).","journal-title":"Immunity"},{"key":"784_CR12","doi-asserted-by":"publisher","first-page":"420.e7","DOI":"10.1016\/j.immuni.2023.01.013","volume":"56","author":"D Ivanochko","year":"2023","unstructured":"Ivanochko, D. et al. Potent transmission-blocking monoclonal antibodies from naturally exposed individuals target a conserved epitope on Plasmodium falciparum Pfs230. Immunity 56, 420.e7\u2013432.e7 (2023).","journal-title":"Immunity"},{"key":"784_CR13","doi-asserted-by":"publisher","first-page":"3367","DOI":"10.1016\/j.vaccine.2023.04.042","volume":"41","author":"LM Simons","year":"2023","unstructured":"Simons, L. M. et al. Extending the range of Plasmodium falciparum transmission blocking antibodies. Vaccine 41, 3367\u20133379 (2023).","journal-title":"Vaccine"},{"key":"784_CR14","doi-asserted-by":"publisher","first-page":"19913","DOI":"10.1074\/jbc.M116.732305","volume":"291","author":"NJ MacDonald","year":"2016","unstructured":"MacDonald, N. J. et al. Structural and immunological characterization of recombinant 6-cysteine domains of the Plasmodium falciparum sexual stage protein Pfs230. J. Biol. Chem. 291, 19913\u201319922 (2016).","journal-title":"J. Biol. Chem."},{"key":"784_CR15","doi-asserted-by":"publisher","first-page":"2529","DOI":"10.1042\/BCJ20220554","volume":"479","author":"MH Dietrich","year":"2022","unstructured":"Dietrich, M. H. et al. Nanobodies against Pfs230 block Plasmodium falciparum transmission. Biochem. J. 479, 2529\u20132546 (2022).","journal-title":"Biochem. J."},{"key":"784_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-021-00366-9","volume":"6","author":"RM de Jong","year":"2021","unstructured":"de Jong, R. M. et al. Monoclonal antibodies block transmission of genetically diverse Plasmodium falciparum strains to mosquitoes. NPJ Vaccines 6, 101 (2021).","journal-title":"NPJ Vaccines"},{"key":"784_CR17","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1084\/jem.162.5.1460","volume":"162","author":"AN Vermeulen","year":"1985","unstructured":"Vermeulen, A. N. et al. Sequential expression of antigens on sexual stages of Plasmodium falciparum accessible to transmission-blocking antibodies in the mosquito. J. Exp. Med. 162, 1460\u20131476 (1985).","journal-title":"J. Exp. Med."},{"key":"784_CR18","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1006\/expr.1995.1003","volume":"80","author":"W Roeffen","year":"1995","unstructured":"Roeffen, W. et al. Plasmodium falciparum: a comparison of the activity of Pfs230-specific antibodies in an assay of transmission-blocking immunity and specific competition ELISAs. Exp. Parasitol. 80, 15\u201326 (1995).","journal-title":"Exp. Parasitol."},{"key":"784_CR19","doi-asserted-by":"publisher","DOI":"10.1186\/s12936-022-04173-y","volume":"21","author":"C Mulamba","year":"2022","unstructured":"Mulamba, C., Williams, C., Kreppel, K., Ouedraogo, J. B. & Olotu, A. I. Evaluation of the Pfs25-IMX313\/Matrix-M malaria transmission-blocking candidate vaccine in endemic settings. Malar. J. 21, 159 (2022).","journal-title":"Malar. J."},{"key":"784_CR20","doi-asserted-by":"publisher","first-page":"102227","DOI":"10.1016\/j.mib.2022.102227","volume":"70","author":"PE Duffy","year":"2022","unstructured":"Duffy, P. E. Current approaches to malaria vaccines. Curr. Opin. Microbiol. 70, 102227 (2022).","journal-title":"Curr. Opin. Microbiol."},{"key":"784_CR21","doi-asserted-by":"crossref","unstructured":"Sagara, I. et al. Malaria transmission-blocking vaccines Pfs230D1-EPA and Pfs25-EPA in Alhydrogel in healthy Malian adults; a phase 1, randomised, controlled trial. Lancet Infect. Dis. 23, 1266\u20131279 (2023).","DOI":"10.1016\/S1473-3099(23)00276-1"},{"key":"784_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-018-0065-5","volume":"3","author":"GE Canepa","year":"2018","unstructured":"Canepa, G. E. et al. Antibody targeting of a specific region of Pfs47 blocks Plasmodium falciparum malaria transmission. NPJ Vaccines 3, 26 (2018).","journal-title":"NPJ Vaccines"},{"key":"784_CR23","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1080\/14760584.2017.1276833","volume":"16","author":"M Theisen","year":"2017","unstructured":"Theisen, M., Jore, M. M. & Sauerwein, R. Towards clinical development of a Pfs48\/45-based transmission blocking malaria vaccine. Expert Rev. Vaccines 16, 329\u2013336 (2017).","journal-title":"Expert Rev. Vaccines"},{"key":"784_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-21955-1","volume":"12","author":"CH Coelho","year":"2021","unstructured":"Coelho, C. H. et al. A human monoclonal antibody blocks malaria transmission and defines a highly conserved neutralizing epitope on gametes. Nat. Commun. 12, 1750 (2021).","journal-title":"Nat. Commun."},{"key":"784_CR25","doi-asserted-by":"crossref","unstructured":"Healy, S. A. et al. Pfs230 yields higher malaria transmission-blocking vaccine activity than Pfs25 in humans but not mice. J. Clin. Invest. 131, e146221 (2021).","DOI":"10.1172\/JCI146221"},{"key":"784_CR26","first-page":"e4613","volume":"13","author":"CLM Gall","year":"2023","unstructured":"Gall, C. L. M., Fennemann, F. L., Van Der Schoot, J. M. S., Scheeren, F. A. & Verdoes, M. CRISPR\/Cas9-based engineering of immunoglobulin loci in hybridoma cells. Bio Protoc. 13, e4613 (2023).","journal-title":"Bio Protoc."},{"key":"784_CR27","doi-asserted-by":"crossref","unstructured":"van Elsas, M. J. et al. Regulatory T cell depletion using a CRISPR Fc-optimized CD25 antibody. Int. J. Mol. Sci. 23, 8707 (2022).","DOI":"10.3390\/ijms23158707"},{"key":"784_CR28","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1021\/acs.bioconjchem.0c00673","volume":"32","author":"CM Le Gall","year":"2021","unstructured":"Le Gall, C. M. et al. Dual site-specific chemoenzymatic antibody fragment conjugation using CRISPR-based hybridoma engineering. Bioconjug. Chem. 32, 301\u2013310 (2021).","journal-title":"Bioconjug. Chem."},{"key":"784_CR29","doi-asserted-by":"publisher","first-page":"eaaw1822","DOI":"10.1126\/sciadv.aaw1822","volume":"5","author":"JMS van der Schoot","year":"2019","unstructured":"van der Schoot, J. M. S. et al. Functional diversification of hybridoma-produced antibodies by CRISPR\/HDR genomic engineering. Sci. Adv. 5, eaaw1822 (2019).","journal-title":"Sci. Adv."},{"key":"784_CR30","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1128\/iai.63.2.467-471.1995","volume":"63","author":"W Roeffen","year":"1995","unstructured":"Roeffen, W. et al. Transmission blockade of Plasmodium falciparum malaria by anti-Pfs230-specific antibodies is isotype dependent. Infect. Immun. 63, 467\u2013471 (1995).","journal-title":"Infect. Immun."},{"key":"784_CR31","doi-asserted-by":"publisher","first-page":"4213","DOI":"10.4049\/jimmunol.139.12.4213","volume":"139","author":"IA Quakyi","year":"1987","unstructured":"Quakyi, I. A. et al. The 230-kDa gamete surface protein of Plasmodium falciparum is also a target for transmission-blocking antibodies. J. Immunol. 139, 4213\u20134217 (1987).","journal-title":"J. Immunol."},{"key":"784_CR32","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1111\/j.1365-3024.1994.tb00305.x","volume":"16","author":"D Read","year":"1994","unstructured":"Read, D. et al. Transmission-blocking antibodies against multiple, non-variant target epitopes of the Plasmodium falciparum gamete surface antigen Pfs230 are all complement-fixing. Parasite Immunol. 16, 511\u2013519 (1994).","journal-title":"Parasite Immunol."},{"key":"784_CR33","doi-asserted-by":"publisher","first-page":"2623","DOI":"10.1016\/j.vaccine.2014.03.020","volume":"32","author":"M Theisen","year":"2014","unstructured":"Theisen, M. et al. A multi-stage malaria vaccine candidate targeting both transmission and asexual parasite life-cycle stages. Vaccine 32, 2623\u20132630 (2014).","journal-title":"Vaccine"},{"key":"784_CR34","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1128\/CVI.05105-11","volume":"18","author":"CE Farrance","year":"2011","unstructured":"Farrance, C. E. et al. A plant-produced Pfs230 vaccine candidate blocks transmission of Plasmodium falciparum. Clin. Vaccin. Immunol. 18, 1351\u20131357 (2011).","journal-title":"Clin. Vaccin. Immunol."},{"key":"784_CR35","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.3389\/fimmu.2019.01256","volume":"10","author":"SK Singh","year":"2019","unstructured":"Singh, S. K. et al. Pfs230 and Pfs48\/45 fusion proteins elicit strong transmission-blocking antibody responses against Plasmodium falciparum. Front. Immunol. 10, 1256 (2019).","journal-title":"Front. Immunol."},{"key":"784_CR36","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1038\/227680a0","volume":"227","author":"UK Laemmli","year":"1970","unstructured":"Laemmli, U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227, 680\u2013685 (1970).","journal-title":"Nature"},{"key":"784_CR37","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1126\/science.1231143","volume":"339","author":"L Cong","year":"2013","unstructured":"Cong, L. et al. Multiplex genome engineering using CRISPR\/Cas systems. Science 339, 819\u2013823 (2013).","journal-title":"Science"},{"key":"784_CR38","doi-asserted-by":"publisher","first-page":"e0124633","DOI":"10.1371\/journal.pone.0124633","volume":"10","author":"M Stemmer","year":"2015","unstructured":"Stemmer, M., Thumberger, T., Del Sol Keyer, M., Wittbrodt, J. & Mateo, J. L. CCTop: an intuitive, flexible and reliable CRISPR\/Cas9 target prediction tool. PLoS ONE 10, e0124633 (2015).","journal-title":"PLoS ONE"},{"key":"784_CR39","doi-asserted-by":"publisher","first-page":"60","DOI":"10.4269\/ajtmh.1995.52.60","volume":"52","author":"W Roeffen","year":"1995","unstructured":"Roeffen, W. et al. A comparison of transmission-blocking activity with reactivity in a Plasmodium falciparum 48\/45-kD molecule-specific competition enzyme-linked immunosorbent assay. Am. J. Trop. Med. Hyg. 52, 60\u201365 (1995).","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"784_CR40","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1084\/jem.157.6.1947","volume":"157","author":"F Zavala","year":"1983","unstructured":"Zavala, F., Cochrane, A. H., Nardin, E. H., Nussenzweig, R. S. & Nussenzweig, V. Circumsporozoite proteins of malaria parasites contain a single immunodominant region with two or more identical epitopes. J. Exp. Med. 157, 1947\u20131957 (1983).","journal-title":"J. Exp. Med."},{"key":"784_CR41","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.molbiopara.2006.05.015","volume":"149","author":"BC van Schaijk","year":"2006","unstructured":"van Schaijk, B. C. et al. Pfs47, paralog of the male fertility factor Pfs48\/45, is a female specific surface protein in Plasmodium falciparum. Mol. Biochem. Parasitol. 149, 216\u2013222 (2006).","journal-title":"Mol. Biochem. Parasitol."},{"key":"784_CR42","doi-asserted-by":"publisher","DOI":"10.1038\/srep03418","volume":"3","author":"WJ Stone","year":"2013","unstructured":"Stone, W. J. et al. The relevance and applicability of oocyst prevalence as a read-out for mosquito feeding assays. Sci. Rep. 3, 3418 (2013).","journal-title":"Sci. Rep."},{"key":"784_CR43","doi-asserted-by":"publisher","first-page":"1680.e8","DOI":"10.1016\/j.immuni.2022.07.015","volume":"55","author":"B McLeod","year":"2022","unstructured":"McLeod, B. et al. Vaccination with a structure-based stabilized version of malarial antigen Pfs48\/45 elicits ultra-potent transmission-blocking antibody responses. Immunity 55, 1680.e8\u20131692.e8 (2022).","journal-title":"Immunity"},{"key":"784_CR44","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/S0166-6851(99)00201-7","volume":"106","author":"SR Brooks","year":"2000","unstructured":"Brooks, S. R. & Williamson, K. C. Proteolysis of Plasmodium falciparum surface antigen, Pfs230, during gametogenesis. Mol. Biochem. Parasitol. 106, 77\u201382 (2000).","journal-title":"Mol. Biochem. Parasitol."}],"container-title":["npj Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41541-023-00784-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41541-023-00784-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41541-023-00784-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,12]],"date-time":"2023-12-12T18:08:57Z","timestamp":1702404537000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41541-023-00784-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,12]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["784"],"URL":"https:\/\/doi.org\/10.1038\/s41541-023-00784-x","relation":{},"ISSN":["2059-0105"],"issn-type":[{"value":"2059-0105","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,12]]},"assertion":[{"value":"8 August 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 November 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"186"}}